Cardiovascular Health

Does C-reactive Protein Have a Place in the CVD Risk Pantheon?

By Michael Traub, ND - Vol. 8, No. 1. , 2007

One of the hottest debates in cardiology for the past few years centers on the question of whether C-reactive protein is a meaningful risk indicator for heart disease. It clearly correlates with a tendency toward inflammation, but is it truly causative? Dr. Traub contends that even if there’s no direct causal relationship, an elevated CRP is telling you that something’s wrong—something that warrants attention.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

In the Thick of It: Blood Viscosity Emerges as Key Heart Risk Factor

By August West | Contributing Writer - Vol. 8, No. 1. , 2007

Blood viscosity, the actual thickness of a person’s blood, is emerging as an important risk factor for heart disease: thicker blood means higher risk. New technology will soon enable doctors to measure viscosity routinely. Best of all, an enzyme derived from the Japanese soy food called natto, can effectively lower blood viscosity with minimal risk of side effects.

Rethinking Hyperlipidemia and Natural Treatment Options for Women at Risk

By Tori Hudson, ND | Contributing Writer - Vol. 7, No. 3. , 2006

A recent metanalysis is challenging the notion that soy protein and soy isoflavones can improve women’s cholesterol profiles. But the study did not account for the fact that some women convert soy isoflavones into equol, a powerful phytoestrogen, while others do not. In a separate study, German researchers found that policosanol, a sugar cane derived substance, had no meaningful effect on lipid profiles or cardiovascular risk.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

Vitamin E Supplements Raise Blood Pressure in Hypertensive People with Type 2 Diabetes

By Erik L. Goldman | Editor in Chief - Vol. 7, No. 3. , 2006

An Australian study shows that vitamin E can actually raise blood pressure in hypertensive patients with Type 2 Diabetes. Though it is not clear whether this occurs in people without hypertension, the data suggest that diabetics need to be very careful with this antioxidant vitamin.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

Melatonin: Circadian Cycle Regulator Has Role in Treatment of Cancer, Hypertension

By Erik L. Goldman | Editor in Chief - Vol. 7, No. 3. , 2006

Most people think of melatonin as a sleep aid and jet lag remedy, owing to its ability to regulate circadian rhythms. But this compound has many other benefits, including regulation of blood pressure and slowing the growth of several types of cancer.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

Obesity: WAT’s Up With That?

By Erik Goldman | Editor in Chief - Vol. 7, No. 2. , 2006

White Adipose Tissue (WAT), the raw material of love handles, secretes a wide range of signaling substances that can radically change metabolism. Dr. Jay Udani reviews the new science emerging on this topic, and explains why it becomes progressively more difficult for obese people to lose weight, even when they try very hard.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

High-Dose Vitamin D Shows Anti-Inflammatory Effects in CHF

By Erik Goldman | Editor in Chief - Vol. 7, No. 2. , 2006

Vitamin D deficiency correlates strongly with many heart disease risk factors. A new study from Germany shows that vitamin D supplementation produces beneficial anti-inflammatory changes in patients with congestive heart failure (CHF).

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

Managing Blood Pressure with C12-Peptide

By Wendeline Wouters, PhD & Stacey J. Bell, DSc, RD - Vol. 7, No. 1. , 2006

A bioactive peptide found in cow’s milk has ACE-inhibitory effects, and holds promise as a natural therapy for lowering blood pressure in people with early-stage hypertension.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

Elevated ADMA Predicts Cardiovascular Risk

By Janet Gulland | Contributing Writer - Vol. 6, No. 3. , 2005

Elevated levels of asymmetric dimethyl arginine (ADMA) is emerging as a serious risk factor for cardiovascular disease, one for which physicians should routinely test. Fortunately, the problem can be reversed by supplementation with L-arginine.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

To Lower CRP, Look to Multivitamins and Lifestyle Change

By Janet Gulland | Contributing Writer - Vol. 6, No. 1. , 2005

A good multivitamin and some modest lifestyle changes can markedly reduce C-reactive protein, a marker of inflammation that correlates strongly with risk of heart attacks, according to a study by physicians at Dallas

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.